Dassault Systèmes

In today’s hyper-competitive biopharmaceutical industry, incremental efficiency gains are not enough to stay ahead of the competition in bringing products to market. Although the digitalization of the laboratory is well underway, there remain opportunities to transform procedures and make step-change gains in efficiency.

The advent of the fully digital lab has led to standardized procedures and data, simplified workflows, and better collaboration. At the same time, organizations have begun to use digital solutions to optimize the use of resources and the workloads of scientists in their labs. Now, it is possible to directly integrate automated schedule and resource optimization with digitalized procedure management and execution systems in the lab.

• How to optimize schedules among available scientists by leveraging resource availability and procedure information.

• How to further streamline lab workflows and remove non value-added tasks with optimized work schedules.

• How to power the transformation of your lab and gain an edge on your competition with this new integration.

Thomas Muth, Global Strategic Industry Development Director, Dassault Systèmes

Stephen Hayward, Technical Marketing Manager, Dassault Systèmes

On demand available after final airing until Dec. 8, 2021

Webcasts

***December 8, 2020 at 10am EST| 3pm GMT| 4pm CET*** Join this live webcast to learn more about a unique and powerful integration between lab scheduling and lab procedure execution, leading to an 80% reduction in time spent planning and organizing work as well as 10x reduction in compliance risk through standardized processes..*** On demand available after final airing until Dec. 8, 2021.***



Transform Your Lab Workflows and Resource Utilization

	Due to the high cost of bringing a single new therapeutic to the market and considering that programs for innovative products are high-risk/high-reward, the most innovative Life Sciences companies are turning to novel formulation strategies and delivery systems that can vastly improve the patient experience-the next frontier in drug development. Join our experts live on September 25th, to learn about IASO, a showcase of a combination product in oncology demonstrating the value that Dassault Systèmes and the 3DEXPERIENCE® platform can deliver to stakeholders challenged with bringing innovation to market in the form of combination products - transforming the patient experience.

		Gain insight and knowledge of the life science industry shift toward biologics and the delivery devices required to deliver them

		Gain a high-level understanding of the value the 3DEXPERIENCE® platform can offer to companies bringing innovating combination products (delivery devices) to market

		Learn how the 3DEXPERIENCE® platform can be used in each of the following areas: collaborative design, therapeutic design and development, device design and development, manufacturing excellence and enterprise operational excellence

Sara Dutta, Life Sciences Industry Business Consultant, Dassault Systèmes

	Guillaume Kerboul, Business Consultant Director, Dassault Systèmes

 Wednesday, Sept. 25, 2019 at 9am EDT | 2pm BST | 3pm CEST

	On demand available after airing until Sept. 25, 2020

In this webcast, experts from Dassault Systèmes will demonstrate the core value of Dassault Systèmes’ 3DEXPERIENCE® platform: modeling and simulation, with end-to-end digital continuity and data integrity.. 

Live: Wednesday, Sept. 25, 2019 at 9am EDT | 2pm BST | 3pm CEST

On demand available after airing until Sept. 25, 2020

Register free


Dassault Systèmes

Articles